why choose us

First received: January 05, 2023

Clinical Trial: Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Female Sexual Arousal Disorder

Study Type: INTERVENTIONAL


Official Title: Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women

Brief Summary: Antidepressants have negative effects on genital arousal function that hinder quality of life and jeopardize medication adherence.Moderate sympathetic nervous system (SNS) activation through exercise has shown promising results for improving antidepressant-induced genital arousal dysfunction.It is feasible that caffeine - an SNS stimulant - could improve antidepressant-induced genital arousal difficulties if ingested prior to sex.The goal of the present pilot study is to examine whether the acute administration of…

Read more